Find uplifting stories about heroes, innovations, and solutions
11 results for "obesity treatment"
Doctors at Mayo Clinic are successfully pairing weight loss surgery with medications like Ozempic to help patients overcome obesity. This combined approach offers new hope for people who need more support than one treatment alone can provide.
Pharmaceutical giant Eli Lilly achieved positive results in nearly all its 2025 clinical trials, bringing new treatments for obesity, diabetes, and cancer closer to patients who need them. The company is also building the world's largest pharmaceutical AI supercomputer to speed up future drug discoveries.
Consumer advocates are asking the government to authorize cheaper versions of popular weight loss and diabetes medications that millions of Americans can't afford. The move could help patients nationwide access drugs that have been out of reach due to high prices.
Researchers discovered a brain pathway that eliminates body fat in mice without changing their eating habits. This breakthrough could one day help treat both severe weight loss disorders and obesity.
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.
Doctors are discovering why weight-loss drugs work brilliantly for some people but fail for others. The answer could revolutionize how we treat obesity within just a few years.
Novo Nordisk's pill version of the blockbuster weight loss drug Wegovy is launching with impressive momentum. The oral alternative to injections could make life-changing treatment easier for millions.
Popular weight loss medications are showing an unexpected benefit for people with chronic sinus problems and obesity. A five-year study found patients taking these drugs needed 40% fewer repeat surgeries after sinus operations.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A drug that flopped in Alzheimer's trials just helped obese mice lose 20% of their body weight without eating less or exercising more. Johns Hopkins researchers are now testing whether this accidental discovery could help millions of people struggling with severe obesity.